Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $42.2 million.

  • Prestige Consumer Healthcare's Net Income towards Common Stockholders fell 22.37% to $42.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.8 million, marking a year-over-year decrease of 2.48%. This contributed to the annual value of $214.6 million for FY2025, which is 2.52% up from last year.
  • Prestige Consumer Healthcare's Net Income towards Common Stockholders amounted to $42.2 million in Q3 2025, which was down 11.07% from $47.5 million recorded in Q2 2025.
  • Prestige Consumer Healthcare's Net Income towards Common Stockholders' 5-year high stood at $61.0 million during Q4 2024, with a 5-year trough of -$240.6 million in Q1 2023.
  • For the 3-year period, Prestige Consumer Healthcare's Net Income towards Common Stockholders averaged around $24.8 million, with its median value being $50.1 million (2025).
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Net Income towards Common Stockholders plummeted by 561.84% in 2023, and later soared by 120.56% in 2024.
  • Over the past 5 years, Prestige Consumer Healthcare's Net Income towards Common Stockholders (Quarterly) stood at $50.2 million in 2021, then increased by 3.46% to $52.0 million in 2022, then increased by 2.11% to $53.0 million in 2023, then increased by 15.05% to $61.0 million in 2024, then decreased by 22.37% to $42.2 million in 2025.
  • Its Net Income towards Common Stockholders stands at $42.2 million for Q3 2025, versus $47.5 million for Q2 2025 and $50.1 million for Q1 2025.